Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients—authors' response.
| Autor: | Wu, Tzong-Yow1 (AUTHOR), Chen, Pao-Yu1,2 (AUTHOR), Wang, Jann-Tay1,3 (AUTHOR), Liu, Wang-Da4 (AUTHOR), Chen, Yee-Chun1,3,5 (AUTHOR), Chang, Shan-Chwen1,5 (AUTHOR) changsc@ntu.edu.tw |
|---|---|
| Zdroj: | Journal of Antimicrobial Chemotherapy (JAC). Dec2024, Vol. 79 Issue 12, p3360-3361. 2p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|